Results 281 to 290 of about 960,807 (326)

Changes in Plasma Sphingolipid Metabolites Following Roux‐En‐Y Gastric Bypass in Women With Obesity and Type 2 Diabetes: A Pilot Metabolomic Cohort Study

Lipids, EarlyView.
ABSTRACT Although sphingolipids are key players in lipotoxicity and metabolic diseases, their response to bariatric surgery and their relation to metabolic improvement remain unclear. This pilot study investigated plasma sphingolipid remodeling after Roux‐en‐Y gastric bypass (RYGB) and its associations with clinical and biochemical markers of ...
Gabriela de Oliveira Lemos, Raquel Susana Torrinhas, Natasha Mendonça Machado, Dan Linetzky Waitzberg   +3 more
wiley   +1 more source

Inclisiran in Dyslipidemia with High Residual Platelet Reactivity. [PDF]

Diseases
Kapsultanova D, Zhangelova S, Nurmukhammad F, Makasheva Z, Sakhov O, Galkina T, Rustamova F, Akhmentayeva D, Aubakirova B.   +8 more
europepmc   +1 more source

Prospective evaluation of chemotherapy-induced dyslipidemia in early breast cancer: implications for cardiovascular risk. [PDF]

Front Oncol
Rusinova L, Medvedieva J, Santova Z, Kozarova M.   +3 more
europepmc   +1 more source

LDL-cholesterol in newborns and children with genetically verified familial hypercholesterolaemia: implications for cholesterol-based screening. [PDF]

Eur Heart J
Bogsrud MP, Stava TT, Berge KE, Strøm TB, Retterstøl K, Holven KB.   +5 more
europepmc   +1 more source

Lipid metabolism in colorectal cancer: dual roles and statin therapy. [PDF]

Discov Oncol
Lu P, Wang Z.
europepmc   +1 more source

Association of oil spill-related volatile organic compound exposure with CVD-related biomarkers in the Gulf Long-term Follow-up Study. [PDF]

Ann Work Expo Health
Patel OP, Edwards JK, Kucharska-Newton AM, Whitsel EA, Christenbury K, Jackson WB, Lawrence KG, Stewart PA, Stenzel MR, Sandler DP, Engel LS.   +10 more
europepmc   +1 more source